Menu
Currency
GWAS Study

Shared and Distinct Genomics of Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Embolism.

Liley J, Newnham M, Bleda M et al.

38470220 PubMed ID
GWAS Study Type
12264 Participants
138 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

LJ
Liley J
NM
Newnham M
BM
Bleda M
BK
Bunclark K
AW
Auger W
BJ
Barbera JA
BH
Bogaard H
DM
Delcroix M
FT
Fernandes TM
HL
Howard L
JD
Jenkins D
LI
Lang I
ME
Mayer E
RC
Rhodes C
SM
Simpson M
SL
Southgate L
TR
Trembath R
WJ
Wharton J
WM
Wilkins MR
GS
Gräf S
MN
Morrell N
ZJ
Zaba JP
TM
Toshner M
Chapter II

Abstract

Summary of the research findings

Rationale: Chronic thromboembolic pulmonary hypertension involves the formation and nonresolution of thrombus, dysregulated inflammation, angiogenesis, and the development of a small-vessel vasculopathy. Objectives: We aimed to establish the genetic basis of chronic thromboembolic pulmonary hypertension to gain insight into its pathophysiological contributors. Methods: We conducted a genome-wide association study on 1,907 European cases and 10,363 European control subjects. We coanalyzed our results with existing results from genome-wide association studies on deep vein thrombosis, pulmonary embolism, and idiopathic pulmonary arterial hypertension. Measurements and Main Results: Our primary association study revealed genetic associations at the ABO, FGG, F11, MYH7B, and HLA-DRA loci. Through our coanalysis, we demonstrate further associations with chronic thromboembolic pulmonary hypertension at the F2, TSPAN15, SLC44A2, and F5 loci but find no statistically significant associations shared with idiopathic pulmonary arterial hypertension. Conclusions: Chronic thromboembolic pulmonary hypertension is a partially heritable polygenic disease, with related though distinct genetic associations with pulmonary embolism and deep vein thrombosis.

1,901 cases, 10,363 controls

Chapter III

Study Statistics

Key metrics and study information

12264
Total Participants
GWAS
Study Type
No
Replicated
U.K.
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.